These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21316540)

  • 21. Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).
    Bassetti M; Di Biagio A; Cenderello G; Del Bono V; Palermo A; Cruciani M; Bassetti D
    J Infect; 2001 Aug; 43(2):148-9. PubMed ID: 11676523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.
    Menzin J; Marton JP; Meyers JL; Carson RT; Rothermel CD; Friedman M
    Am J Infect Control; 2010 Feb; 38(1):44-9. PubMed ID: 19762120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Sharpe JN; Shively EH; Polk HC
    Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM; Weigelt J; Li JZ; Duttagupta S
    Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Sotgiu G; Lange C; Richardson MD; Matteelli A; Centis R; Eker B; Guenther G; Spanevello A; Migliori GB;
    J Antimicrob Chemother; 2009 Oct; 64(4):879-83; author reply 883-4. PubMed ID: 19651787
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients.
    Kosaka T; Kokufu T; Shime N; Sugioka N; Kato R; Hamaoka K; Fujita N
    Int J Antimicrob Agents; 2009 Apr; 33(4):368-70. PubMed ID: 19097868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
    Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
    Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effects.
    Nathwani D; Li JZ; Balan DA; Willke RJ; Rittenhouse BE; Mozaffari E; Tavakoli M; Tang T
    Int J Antimicrob Agents; 2004 Apr; 23(4):315-24. PubMed ID: 15081078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Linezolide in paediatrics].
    Moulin F; Ménager C
    Arch Pediatr; 2010 Sep; 17 Suppl 4():S133-9. PubMed ID: 20826321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
    Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
    Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany.
    Schürmann D; Sorensen SV; De Cock E; Duttagupta S; Resch A
    Eur J Health Econ; 2009 Feb; 10(1):65-79. PubMed ID: 18437437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Out-of-pocket costs and prescription reversals with oral linezolid.
    Pasquale MK; Louder AM; Deminski MC; Chambers RB; Haider S
    Am J Manag Care; 2013 Sep; 19(9):734-40. PubMed ID: 24304256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
    Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
    Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of linezolid on hospital length of stay compared with vancomycin in treatment of methicillin-resistant Staphylococcus infections. An application of multivariate survival analysis.
    Willke RJ; Glick HA; Li JZ; Rittenhouse BE
    Int J Technol Assess Health Care; 2002; 18(3):540-54. PubMed ID: 12391947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
    De Gascun C; Rajan L; O'Neill E; Smyth EG
    J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
    [No Abstract]   [Full Text] [Related]  

  • 37. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.
    Wilcox M; Nathwani D; Dryden M
    J Antimicrob Chemother; 2004 Feb; 53(2):335-44. PubMed ID: 14729745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linezolid.
    Narang M; Gomber S
    Indian Pediatr; 2004 Nov; 41(11):1129-32. PubMed ID: 15591662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of linezolid with oxacillin or vancomycin in the empiric treatment of cellulitis in US hospitals.
    Vinken AG; Li JZ; Balan DA; Rittenhouse BE; Willke RJ; Goodman C
    Am J Ther; 2003; 10(4):264-74. PubMed ID: 12845390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of linezolid in pediatrics: a critical review.
    Dotis J; Iosifidis E; Ioannidou M; Roilides E
    Int J Infect Dis; 2010 Aug; 14(8):e638-48. PubMed ID: 20106697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.